Antiseptic compositions and methods

US2016184346A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016184346-A1
Application numberUS-201615062493-A
CountryUS
Kind codeA1
Filing dateMar 7, 2016
Priority dateJan 16, 2002
Publication dateJun 30, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A skin antisepsis composition comprising a vehicle comprising a (C1-4)alcohol and water in a ratio of at least 60:40, a hydroxycarboxylic acid, a cationic film-forming polymer, and at least one antimicrobial agent; and methods of using the composition are provided.

First claim

Opening claim text (preview).

1 . An antiseptic composition for use in disinfecting tissue, wherein the antiseptic composition comprises: an antimicrobial agent selected from the group consisting of iodine, an iodophor, and a combination thereof, wherein the antimicrobial agent is present in an amount sufficient to provide an available iodine concentration of at least 0.25 wt-%; a hydroxycarboxylic acid buffer in a molar concentration of at least 0.3 molar; and water. 2 . The antiseptic composition for use according to claim 1 , wherein the antiseptic composition further includes one or more nonionic, anionic, or amphoteric surfactants. 3 . The antiseptic composition for use according to claim 2 , wherein the surfactant is an anionic or amphoteric surfactant. 4 . The antiseptic composition for use according to claim 3 , wherein the anionic or amphoteric surfactant is selected from the group consisting of sulfonates, sulfates, phosphates, phosphonates, and ammonium sulfonate amphoterics, and mixtures thereof. 5 . The antiseptic composition for use according to claim 4 , wherein the hydroxycarboxylic acid buffer is present in a molar concentration of at least 0.45 molar. 6 . The antiseptic composition for use according to claim 1 , wherein the antiseptic composition further includes a film-forming polymer. 7 . The antiseptic composition for use according to claim 6 , wherein the film-forming polymer is cationic. 8 . The antiseptic composition for use according to claim 1 wherein the iodophor is povidone-iodine. 9 . The antiseptic composition for use according to claim 1 wherein the tissue is skin or mucosal tissue. 10 . The antiseptic composition for use according to claim 9 , wherein the mucosal tissue is nasal or vaginal tissue. 11 . The antiseptic composition for use according to claim 10 , wherein the mucosal tissue is nasal tissue. 12 . The antiseptic composition for use according to claim 1 , wherein the antiseptic composition is to be directly applied to the tissue and is to remain on the tissue. 13 . The antiseptic composition for use according to claim 12 , wherein the antiseptic composition is to be applied prior to surgery, catheterization, or needle puncture. 14 . Use of a hydroxycarboxylic acid buffer for the preparation of an antiseptic composition for disinfecting tissue, wherein the antiseptic composition is as defined in claim 1 . 15 . The use according to claim 14 , wherein the tissue is skin or mucosal tissue. 16 . The use according to claim 15 , wherein the mucosal tissue is nasal or vaginal tissue. 17 . The use according to claim 16 , wherein the mucosal tissue is nasal tissue. 18 . The use according to claim 14 , wherein the antiseptic composition is to be directly applied to the tissue and is to remain on the tissue. 19 . The use according to claim 14 , wherein the antiseptic composition is to be applied prior to surgery, catheterization, or needle puncture.

Assignees

Inventors

Classifications

  • Local antiseptics · CPC title

  • Carboxylic acids; Salts or anhydrides thereof · CPC title

  • A01N59/12Primary

    Iodine, e.g. iodophors; Compounds thereof · CPC title

  • A61K31/79Primary

    Polymers of vinyl pyrrolidone · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016184346A1 cover?
A skin antisepsis composition comprising a vehicle comprising a (C1-4)alcohol and water in a ratio of at least 60:40, a hydroxycarboxylic acid, a cationic film-forming polymer, and at least one antimicrobial agent; and methods of using the composition are provided.
Who is the assignee on this patent?
3M Innovative Properties Co
What technology area does this patent fall under?
Primary CPC classification A01N59/12. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Jun 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).